Centre approves ₹30L to ₹1.23 cr relief in faulty hip implants case | Latest News India - Hindustan Times
close_game
close_game

Centre approves 30L to 1.23 cr relief in faulty hip implants case

Hindustan Times, New Delhi | By
Nov 30, 2018 12:01 AM IST

The drug controller general of India said this is the highest ever compensation amount in the Indian history.

The Union health ministry approved on Thursday compensations between 30 lakh and 1.23 crore for patients who received Johnson & Johnson’s (J&J’s) faulty hip implants before August 2010.

Faulty Articular Surface Replacement (ASR) hip implants, manufactured by DePuy International Limited — a subsidiary of Johnson & Johnson Pvt Ltd, were recalled in 2010 globally after complaints of more-than-usual revision surgeries due to complications such as metal leaching and infections, among others.(Bloomberg/Representative image)
Faulty Articular Surface Replacement (ASR) hip implants, manufactured by DePuy International Limited — a subsidiary of Johnson & Johnson Pvt Ltd, were recalled in 2010 globally after complaints of more-than-usual revision surgeries due to complications such as metal leaching and infections, among others.(Bloomberg/Representative image)

The amount will depend on the age and the level of disability of the person, with younger people with higher disability getting the larger share of the compensation.

Hindustan Times - your fastest source for breaking news! Read now.

“This is the highest ever compensation amount in the Indian history. We have been working on it for almost a year to ensure patients get the maximum benefit. And the company has given us in writing that they will pay the entire amount,” said Dr S Eswara Reddy, the drug controller general of India.

The faulty Articular Surface Replacement (ASR) hip implants, manufactured by DePuy International Limited — a subsidiary of J&J Pvt Ltd, were recalled in 2010 globally after complaints of more-than-usual revision surgeries due to complications such as metal leaching and infections, among others.

J&J maintains that the company’s actions on the product were “appropriate” and “responsible”, and that “voluntary recall doesn’t imply that the product is faulty”. The manufacturers had said they were willing to pay the compensation.

After complaints, the health ministry set up an 11-member panel on February 7, 2017 to investigate them. A report was submitted in February 2018 that recommended a base compensation of 20 lakh.

Based on the recommendations, the government constituted a central expert committee under the chairmanship of Dr RK Arya, director at the Sports Injury Centre, to determine the quantum of compensation.

The committee divided disability in four categories: 20-30%, 30-40%, 40-50% and above 50%. The age group was divided in 10 categories — 20 years and 65 and above. At least 150 patients have registered with the central panel.

All states were also asked to form state-level committees to examine the affected patients. The ministry expects to release of compensation in next 10 days.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On